, Mantell Associates Network
Our CEO, Dr Ross Burn spoke to the Mantell Associates Network podcast about innovation during the COVID-19 pandemic
By: Ross Burn
The key parameters to consider for QbD and control strategy
By: Alan Steven and Jenny Wallis
Leveraging green chemistry to promote a sustainable pharma future
By: Joseph Renny
Solvent Selection Considerations
, The Medicine Maker
Our Chief Operating Officer, Dr Simon Tyler, recently spoke with The Medicine Maker to discuss the continuing impacts of COVID-19 on the pharmaceutical industry
By: Simon Tyler
, Chemicals Knowledge Hub
Our CEO, Dr Ross Burn talked to Chemicals Knowledge Hub TV about the origins of CatSci, our strategic shift and exponential growth over the past few years.
© 2011-2022 CatSci Ltd. All rights reserved.Registered in England & Wales.Company No. 07466141.